BIOMAT Database Logo BIOMAT Database Logo

Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome. 2010

Lothar Bernd Zimmerhackl, and Johannes Hofer, and Gérard Cortina, and Walter Mark, and Reinhard Würzner, and Therese C Jungraithmayr, and Gus Khursigara, and Kay O Kliche, and Wolfgang Radauer

UI MeSH Term Description Entries
D008297 Male Males
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003167 Complement Activation The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES. Activation, Complement,Activations, Complement,Complement Activations
D003176 Complement C3 A glycoprotein that is central in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C3 can be cleaved into COMPLEMENT C3A and COMPLEMENT C3B, spontaneously at low level or by C3 CONVERTASE at high level. The smaller fragment C3a is an ANAPHYLATOXIN and mediator of local inflammatory process. The larger fragment C3b binds with C3 convertase to form C5 convertase. C3 Complement,C3 Precursor,Complement 3,Complement C3 Precursor,Complement Component 3,Precursor-Complement 3,Pro-C3,Pro-Complement 3,C3 Precursor, Complement,C3, Complement,Complement, C3,Component 3, Complement,Precursor Complement 3,Precursor, C3,Precursor, Complement C3,Pro C3,Pro Complement 3
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006463 Hemolytic-Uremic Syndrome A syndrome that is associated with microvascular diseases of the KIDNEY, such as RENAL CORTICAL NECROSIS. It is characterized by hemolytic anemia (ANEMIA, HEMOLYTIC); THROMBOCYTOPENIA; and ACUTE RENAL FAILURE. Gasser's Syndrome,Gasser Syndrome,Gassers Syndrome,Hemolytic Uremic Syndrome,Syndrome, Hemolytic-Uremic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal

Related Publications

Lothar Bernd Zimmerhackl, and Johannes Hofer, and Gérard Cortina, and Walter Mark, and Reinhard Würzner, and Therese C Jungraithmayr, and Gus Khursigara, and Kay O Kliche, and Wolfgang Radauer
[Use of Eculizumab in atypical hemolytic uremic syndrome after renal transplantation].
January 2015, Jornal brasileiro de nefrologia,
Lothar Bernd Zimmerhackl, and Johannes Hofer, and Gérard Cortina, and Walter Mark, and Reinhard Würzner, and Therese C Jungraithmayr, and Gus Khursigara, and Kay O Kliche, and Wolfgang Radauer
[Recurrent atypical hemolytic uremic syndrome after renal transplantation: treatment with eculizumab].
January 2018, Medicina,
Lothar Bernd Zimmerhackl, and Johannes Hofer, and Gérard Cortina, and Walter Mark, and Reinhard Würzner, and Therese C Jungraithmayr, and Gus Khursigara, and Kay O Kliche, and Wolfgang Radauer
Prophylactic eculizumab prior to kidney transplantation for atypical hemolytic uremic syndrome.
August 2011, Pediatric nephrology (Berlin, Germany),
Lothar Bernd Zimmerhackl, and Johannes Hofer, and Gérard Cortina, and Walter Mark, and Reinhard Würzner, and Therese C Jungraithmayr, and Gus Khursigara, and Kay O Kliche, and Wolfgang Radauer
Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation.
December 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
Lothar Bernd Zimmerhackl, and Johannes Hofer, and Gérard Cortina, and Walter Mark, and Reinhard Würzner, and Therese C Jungraithmayr, and Gus Khursigara, and Kay O Kliche, and Wolfgang Radauer
Renal transplantation under prophylactic eculizumab in atypical hemolytic uremic syndrome with CFH/CFHR1 hybrid protein.
July 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
Lothar Bernd Zimmerhackl, and Johannes Hofer, and Gérard Cortina, and Walter Mark, and Reinhard Würzner, and Therese C Jungraithmayr, and Gus Khursigara, and Kay O Kliche, and Wolfgang Radauer
Eculizumab in atypical hemolytic-uremic syndrome.
October 2013, The New England journal of medicine,
Lothar Bernd Zimmerhackl, and Johannes Hofer, and Gérard Cortina, and Walter Mark, and Reinhard Würzner, and Therese C Jungraithmayr, and Gus Khursigara, and Kay O Kliche, and Wolfgang Radauer
Eculizumab in atypical hemolytic-uremic syndrome.
October 2013, The New England journal of medicine,
Lothar Bernd Zimmerhackl, and Johannes Hofer, and Gérard Cortina, and Walter Mark, and Reinhard Würzner, and Therese C Jungraithmayr, and Gus Khursigara, and Kay O Kliche, and Wolfgang Radauer
Eculizumab in atypical hemolytic-uremic syndrome.
October 2013, The New England journal of medicine,
Lothar Bernd Zimmerhackl, and Johannes Hofer, and Gérard Cortina, and Walter Mark, and Reinhard Würzner, and Therese C Jungraithmayr, and Gus Khursigara, and Kay O Kliche, and Wolfgang Radauer
Eculizumab in atypical hemolytic-uremic syndrome.
October 2013, The New England journal of medicine,
Lothar Bernd Zimmerhackl, and Johannes Hofer, and Gérard Cortina, and Walter Mark, and Reinhard Würzner, and Therese C Jungraithmayr, and Gus Khursigara, and Kay O Kliche, and Wolfgang Radauer
Eculizumab in atypical hemolytic-uremic syndrome.
October 2013, The New England journal of medicine,
Copied contents to your clipboard!